Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GenPrime
AddedFeb 16, 2024
UpdatedJun 18, 2026
GenPrime

GenPrime

GenPrime offers microbial detection kits for identifying toxins and microbes, aiding in security threat management.

HQ
Spokane, WA, US
Founded
1997
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance public safety, GenPrime provides advanced microbial detection and diagnostic analysis kits. The company's core vision is to empower police and emergency teams with the tools necessary to detect and manage security threats effectively. Their products are designed to identify dangerous toxins and microbes, including anthrax, ricin, and botulism bacteria, ensuring rapid and accurate threat assessment in critical situations.

GenPrime has garnered attention from notable investors and industry experts due to its innovative approach to microbial detection. The company has achieved significant milestones in improving the speed and reliability of threat detection, making a substantial impact on public safety protocols. By equipping first responders with cutting-edge diagnostic tools, GenPrime plays a crucial role in enhancing preparedness and response capabilities against bioterrorism threats.

GenPrime - Similar Companies

Attogene logo

Attogene

attogene.com

CapForce logo

CapForce

opgen.com

Genendeavor logo

Genendeavor

genendeavor.com

GeneCapture logo

GeneCapture

genecapture.com

PathogenDx logo

PathogenDx

pathogendx.com

Ande logo

Ande

ande.com

Bacterial Barcodes logo

Bacterial Barcodes

Guanine logo

Guanine

guanineinc.com

Evogen logo

Evogen

evogen.com

DxDiscovery logo

DxDiscovery

dxdiscovery.com

GenQual logo

GenQual

genqual.com

Detectachem logo

Detectachem

detectachem.com

BioFlyte logo

BioFlyte

bioflyte.com

Primegen Biotech logo

Primegen Biotech

InstantLabs logo

InstantLabs

GenPrime - Quick Facts

Who are GenPrime's competitors?

Companies similar to GenPrime include Attogene, CapForce, Genendeavor and GeneCapture.

When was GenPrime founded?

GenPrime was founded in 1997.

Where is GenPrime's headquarters located?

GenPrime's headquarters is located in Spokane, WA, US.

When was GenPrime's last funding round?

GenPrime's most recent funding round was for $160k (USD) in January 2013.

How much has GenPrime raised to-date?

As of Jan 10, 2013, GenPrime has raised a total of $3.4M (USD).

How many employees does GenPrime have?

GenPrime has 14 employees as of Feb 5, 2024.

GenPrime - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Government
Main Product
  • Microbial Detection
Tags
  • Security
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research